Rob Woodman

Rob Woodman

Rob Woodman is Senior Partner with Takeda Ventures Inc. and is based in London, UK. He serves as Board director or Observer at the Board of seven TVI portfolio companies, including Emendo Bio Inc, BioMx Ltd. and Hookipa Pharma (Nasdaq: HOOK). Prior to TVI, Rob was Director of Healthcare Investments at Touchstone Innovations. Whilst there, he served on the board of seven Touchstone portfolio companies, including Stanmore Implants Ltd (acquired by Stryker), and played a key role in the funding and/or founding of five companies. Rob was previously Principal in the life science team at Sofinnova Partners, a leading European venture capital firm. Whilst at Sofinnova, Rob was actively involved in seven investments, five of which were acquired or listed. Rob’s experience ranges from technology transfer with Cancer Research Technology (CRUK) through to pharmaceutical consultancy with IMS Health. He holds an MSc in Biochemistry from the University of Oxford and a PhD in Oncology from the University of Cambridge.



< Back to Board